Guided Therapeutics (GTHP) Invested Capital (2010 - 2025)

Guided Therapeutics has disclosed Invested Capital across 16 years of filings, most recently posting -$5.4 million for Q4 2025.

• Invested Capital for Q4 2025 came in at -$5.4 million, down 25.21% year-over-year; the trailing twelve-month figure through Dec 2025 was -$5.4 million (down 25.21% YoY), and the FY2025 annual result was -$5.4 million, down 25.21% from the prior year.
• Invested Capital came in at -$5.4 million for Q4 2025 at Guided Therapeutics, down from -$5.0 million in the prior quarter.
• In the past five years, Invested Capital ranged from a high of -$2.1 million in Q3 2022 to a low of -$7.9 million in Q1 2021.
• The 5-year median for Invested Capital is -$4.4 million (2024), against an average of -$4.5 million.
• Across the five-year window, Invested Capital soared 70.38% in 2022 and slumped 50.27% in 2023, its largest moves.
• Guided Therapeutics' Invested Capital stood at -$5.4 million in 2021, then surged by 57.66% to -$2.3 million in 2022, then slumped by 41.81% to -$3.3 million in 2023, then slumped by 31.45% to -$4.3 million in 2024, then slipped by 25.21% to -$5.4 million in 2025.
• The last three Invested Capital figures came in at -$5.4 million (Q4 2025), -$5.0 million (Q3 2025), and -$4.9 million (Q2 2025), per Business Quant data.